Johnson & Johnson pauses COVID-19 vaccine trial over 'unexplained illness'
Drug-maker Johnson & Johnson says it is temporarily pausing clinical trials of a COVID-19 vaccine due to "an unexplained illness in a study participant."
Johnson & Johnson set to begin crucial COVID-19 vaccine trial with 60,000 people
Janssen Pharmaceutical is planning to recruit about 60,000 participants to test its COVID-19 vaccine.
Johnson & Johnson to provide U.S. government 100 million doses of COVID-19 vaccine
New Jersey-based Johnson & Johnson says it has an agreement to deliver 100 million doses of an investigational vaccine to fight the coronavirus.
Johnson & Johnson warns insulin pumps can be hacked
Johnson & Johnson has issued a written warning to users of its Animas OneTouch Ping insulin pump users that a cyber security issue could allow a person to hack into it using its unencrypted radio frequency communication system.
Johnson & Johnson ordered to pay $72M in talcum cancer lawsuit
A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson's well-known baby powder and other products containing talcum.